Skip to main content
SHIFT Newsroom

Wegovy not working? Preparing for a treatment review

Decorative Wegovy weight stall title card

If your weight is not changing as expected on Wegovy, arrange a review rather than assuming you have failed. Response, prescribed treatment, tolerability and other health factors all deserve consideration. There is no blanket instruction to wait 16–20 weeks or to continue through concerning symptoms. This guide helps you prepare useful information for your prescriber; it does not set a dose or switching plan.


Key points

- Slow progress has several possible explanations and cannot be diagnosed from a weight chart alone.
- Review the exact product and prescribed schedule with your care team.
- Report troublesome symptoms promptly; urgent symptoms need urgent care.
- Tests should be chosen for your circumstances, not ordered as a universal checklist.
- Do not increase, restart or switch treatment using an article.

Common reasons Wegovy may not appear to be working

A review should consider both the treatment and your experience without assuming poor effort or incorrect use. Some people respond less than others even when they follow the plan. It helps to bring reliable records and specific questions rather than trying to identify a single cause yourself.

If treatment is still being adjusted, tell the prescriber exactly what you have taken and for how long. A dose-escalation schedule is intended to manage treatment safely; it is not a promise that appetite or weight will change only after a particular step. You can ask for advice before the end of titration.

Food and activity form part of weight-management care, but a plateau alone does not prove excess eating. Discuss appetite, access to food, symptoms and what is practical in your routine. An honest account is more useful than a stricter diet adopted just before the appointment. If intake is already low, further restriction may be inappropriate.

Ask a pharmacist or prescriber to check administration and storage if you are unsure. Bring the exact product name and instructions. Mention missed doses or supply gaps without embarrassment; this helps them advise safely. Do not take extra doses to make up for a perceived lack of effect.

Topics worth reviewing include:

Plateaus in particular can feel like failure when they're often just the body adjusting. It's worth reading about how to check before panicking about a plateau rather than assuming the treatment has stopped working altogether.

Pro Tip: Keep a simple weekly log of your dose, injection day, and roughly what you've eaten. It takes two minutes and gives your clinician something concrete to work from at your next review.

How Wegovy dosing and timing affect results

Wegovy's dosing schedule is deliberately slow, and that's often the first thing worth checking if results seem disappointing.

The current UK injection instructions use gradual dose escalation, but Wegovy formulations and available doses are not interchangeable. Follow your own prescription and product leaflet. An older graphic showing a single 16–20-week route should not be used to choose a dose. Ask your prescriber what applies to the product you actually receive.

Clinical trials measure group outcomes over defined periods. The STEP 3 trial studied weekly semaglutide with intensive behavioural therapy; it does not establish a personal result or a date before which concerns should be ignored. Comparing your first few weeks with a trial's final average can create an unrealistic expectation.

Useful questions about the schedule include:

A review can happen whenever there is a concern. Do not wait for maintenance or a fixed number of weeks to report symptoms or discuss a lack of progress.

How side effects and tolerability can reduce effectiveness

Tolerability is part of whether treatment is suitable. A lower scale reading is not a good outcome if you cannot eat or drink adequately. Your prescriber may need to reconsider the plan; an article cannot determine the right change.

Digestive symptoms are recognised in the UK product information. Tell the service how severe they are, how long they last and what you can manage to eat and drink. This is more useful than describing every symptom as normal titration.

Do not push through severe symptoms to reach a higher dose. Nor should a coach or app advise you to change doses. Get appropriate clinical advice.

Not all symptoms are equal, though. MHRA guidance for GLP-1 prescribers flags severe abdominal pain as a red flag that needs urgent medical assessment, since it can indicate pancreatitis rather than routine gastrointestinal upset.

For mild symptoms, ask the prescribing team about practical food and fluid measures appropriate to you. If you cannot keep fluids down, symptoms persist or you feel unwell, seek medical advice rather than relying on self-care. Sudden vision loss also needs urgent assessment.

Small balanced meal beside a glass of water

Pro Tip: If nausea is putting you off food entirely rather than just reducing appetite, tell your prescriber. That's a sign to adjust the approach, not just tough it out.

Medical checks and investigations to consider if weight loss stalls

A clinician can consider whether a condition or another medicine is relevant to the change in weight. A plateau does not diagnose a thyroid problem, diabetes or an interaction. Bring new symptoms and medicine changes to the review rather than requesting the same panel of tests for everyone.

Some treatments and health conditions can affect weight, but do not stop a medicine prescribed for another condition. Ask the prescriber to review the whole list, including non-prescription products. If a test is suggested, ask what question it is intended to answer and how the result would change care.

A useful review checklist is:

NICE TA875 sets conditions for NHS use, including specialist-service provision. Those commissioning criteria should not be presented as the licensing conditions for every private prescription. Ask your own service which clinical and funding rules apply.

Practical steps to improve response while staying safe

While waiting for a routine review, keep the plan manageable. These are options to discuss, not a promise that changing habits will overcome an inadequate medicine response:

  1. Keep meals workable: record appetite and difficulties rather than automatically eating less.
  2. Choose suitable movement: adapt activity to your ability and symptoms.
  3. Note sleep and stress: mention persistent problems if they affect daily life.
  4. Describe alcohol and other products honestly: include supplements and non-prescription medicines.
  5. Keep treatment records: note prescribed doses, interruptions and questions for the pharmacist or prescriber.

The NHS's calorie counting guidance is a solid, free starting point for structuring meals around a sensible deficit.

Pro Tip: Pick one change from this list to focus on for a fortnight rather than trying to overhaul everything at once. Consistency beats intensity.

Support should address practical barriers without blaming you for the outcome. Check which parts are clinical care and which are general coaching. Neither a programme nor a tracking tool can guarantee weight loss or replace an individual treatment decision.

Clinical stopping rules, treatment duration and what happens if you stop or switch

Treatment needs review with your prescriber. The current UK Wegovy product information says that, if weight loss is below 5% of starting weight after six months of treatment, the clinician needs to decide whether to continue after considering individual benefits and risks. This is six months on treatment, not six months after reaching a maintenance dose. NHS funding and service criteria are a separate question: check the current pathway with the service responsible for your care. Do not stop, increase or restart treatment using this article.

Stopping isn't necessarily the end of the story, though. Evidence from a withdrawal trial found that continuing semaglutide maintained further weight loss, while switching to placebo led to significant regain, with a statistically significant difference between groups over 48 weeks, according to trial data on maintenance of weight loss. That's a strong signal that whatever weight loss you achieve on Wegovy tends to need an ongoing plan, whether that's continued medication, a structured maintenance approach, or both.

Key points to raise at a review:

Sources

FAQ

Why am I not responding to Wegovy?

There are several possible explanations, including variation in response. Bring your treatment history, weight records and symptoms to a review. Do not assume that a slow result proves poor adherence or that a higher dose is the answer.

How can I speed up weight loss on Wegovy?

Do not try to accelerate treatment by increasing doses, combining medicines or severely restricting food. Discuss whether the goal and plan remain appropriate. Safe care matters more than matching someone else's rate of loss.

Why am I not losing anything on Wegovy?

A review can consider the exact medicine, treatment exposure, symptoms and relevant health factors. You do not need to wait until a particular week to ask for help, and no single online checklist can identify the cause.

Why is Wegovy taking so long to work?

Titration and response vary, but a slow result should not be dismissed automatically. Ask your prescribing service when and how to assess benefit. The injection schedule and a trial's endpoint are different from your personal review needs.

What My Timber can help with

Prepare your dose history, missed doses, symptoms and weight records for a review with your own prescriber. Do not increase, restart or switch medicine on the basis of an online article.

My Timber provides everyday support with food, movement, personal goals and progress records. It does not prescribe medicines, decide doses or provide a clinical review. Medicine assessment, prescribing, dispensing and treatment monitoring belong with your appropriately regulated healthcare provider.

SHIFT's medicine ordering remains closed while a prescribing partner is being commissioned. This page is information, not an invitation to buy prescription medicine or book a SHIFT prescribing assessment.

Editorial correction — 2 October 2026

We removed unsupported descriptions of SHIFT clinical services and unapproved personal attribution where present. This correction does not represent an independent clinical review of the whole article.

Source correction — 3 October 2026: the review interval above is six months of treatment, not six months at maintenance. Checked against section 4.2 of the current UK Wegovy SmPC. This is an editorial source correction, not an independent clinical review.

Source and editorial correction — 3 October 2026

This revision corrects unsupported timelines, universal rules and clinical claims, distinguishes study findings from personal expectations, and clarifies service boundaries. Original publication history is retained. This is an editorial source review, not independent clinical certification.

Related: Weight-management review: questions to take with you | SHIFT.

Last updated .